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ABSTRAK
Kasus ini mengenai seorang pasien dengan getah bening supraklavikula simpul metastasis dari 
adenokarsinoma terlihat melintang di usus besar. Terdapat keluhan batuk dan didiagnosis demam tifoid, bronkitis 
serta metastasis hati. Perut sebah, penurunan berat badan, sembelit, tinja seperti pensil dengan adanya lendir 
dan darah, sakit tulang, dan urin berwarna seperti teh. Pemeriksaan kolonoskopi pertama kali terungkap adanya 
ileitis limfositik dan temuan mikroskopis juga menunjukkan ileitis limfositik. USG dan CT scan mengungkapkan 
metastasis hati yang tidak diketahui asalnya. Berdasarkan tanda dan gejala klinis, kami menduga bahwa 
karsinoma kolorektal adalah temuan utama. Kemudian, kolonoskopi kedua dilakukan dan ditemukan aanya polip 
kecil, yang disertai dengan biopsi dan hasilnya mendukung usus adenokarsinoma berdiferensiasi baik. Hasil 
serupa juga diungkapkan oleh evaluasi histopatologi. Kami melaporkan kasus yang tidak biasa dari hati dan 
supraklavikula metastasis kelenjar getah bening yang timbul dari adenokarsinoma polip kecil dari usus besar.
Kata kunci: metastasis hati, karsinoma kolorektal, kelenjar limfe.
ABSTRACT
We report a patient with supraclavicular lymph node metastasis from an undetectable adenocarcinoma of 
the transverse colon, who presented with cough and was diagnosed with typhoid fever, bronchitis as well as 
liver metastasis. There were an abdominal fullness, weight loss, constipation, pencil-like stool with mucous 
and blood, low-grade fever, bone ache, and tea-color urine. The first colonoscopy revealed lymphocytic ileitis 
and microscopic findings also showed lymphocytic ileitis. Abdominal USG and CT revealed liver metastasis 
of unknown origin. Based on the clinical sign and symptoms, we suspected that colorectal carcinoma was the 
primary site. Then, the second colonoscopy was performed and it revealed a small polyp, which was followed 
with a biopsy and the result supported a well-differentiated colon adenocarcinoma. Similar result was also 
revealed by the histopathological evaluation. This is an unusual case of liver and supraclavicular lymph node 
metastasis arising from a small polyp adenocacinoma of the transverse colon.
Key words: liver metastase, colorectal carcinoma, lymph node.
334
Harijono Achmad                                                                                                                Acta Med Indones-Indones J Intern Med
INTRODUCTION
Colorectal cancer (CRC) remains a major 
public health problem in western countries. 
Each year, worldwide, there are approximately 
400,000 people die from colorectal cancer and 
700,000 new cases are diagnosed. Colorectal 
carcinoma is the second leading cause of death 
from cancer in the US. It is also the third most 
common malignancy in both men (after lung 
and prostate cancers) and women (after lung 
and breast cancers).1 Approximately 60% of 
patients will develop metastatic disease, which 
is localized to the liver alone in half of them.1,2
By the time they are diagnosed, about 25% 
of colon cancers will have extended through the 
bowel wall; whereas cancers of the rectum will 
have spread through the bowel wall in 50%-70% 
of patients and metastasized to lymph nodes in 
50%-60%.1
The most common site of extra lymphatic 
involvement is the liver and the lung is the most 
frequently affected extra-abdominal organ. 
Metastatic liver tumors are largely silent until 
the disease is well advanced.2 Patients with 
metastatic colorectal tumors frequently die 
of hepatic failure due to liver metastasis. The 
overall incidence of colorectal carcinoma (CRC) 
is nearly identical in men and women. The risk of 
developing colorectal tumors begins to increase 
at 40 and rises with age. The incidence of CRC 
is higher in industrialized regions of the world.1
Specific causes of CRC are unknown, but 
nutritional, genetic and familial factors, as well 
as pre-existing diseases, such as inflammatory 
bowel disease or certain cancers, have been 
found to be associated with this cancer. Risk 
factors for the development of CRC include high-
fat diet, daily alcohol use, smoking, decreased 
physical activity and obesity.1
CASE ILLUSTRATION
A 53-year-old male patient presented 
with cough since 1 year ago without sputum 
production. He also had progressive epigastric 
pain for 5 months, accompanied with low-grade 
fever. He had been admitted to a hospital in 
Surabaya a month before and the doctor said that 
he had chronic bronchitis and typhoid fever. He 
had difficulty in passing stool since 5 months 
before admission. He had pencil-like stool 
with mucous and blood and passed tea-color 
urine since 2 weeks before admission. His lost 
11-kilograms in the last 5 months.
He also said that he had bone ache since 37 
years ago (1972), and he used to consume herbal 
medicine called Puyer Bintang Toed Joe since 
1975 (34 years), once a month, and he started 
to consume Jamu Tawon Api since 6 years ago 
as his pain developed progressively. He usually 
works using a lot of physical strengh. He has 
never suffered from frequent unperceived trauma 
or had fallen in his daily life. He used to drink 
alcohol from 1985 to 1990 and drank half a bottle 
per week. He used to smoke 10 cigarettes per day 
when he was young.
Then, since there were no improvements 
of his condition, he met an internist in Malang, 
and he consulted his illness to the Department of 
Gastroenterohepatology. The cough was relieved 
after he had received steroid injection.
On physical examination, the patient was 
in mildly ill condition. He was fully conscious 
with blood pressure of 110/80 mmHg, pulse 
rate at 80 beats per minute, respiratory rate was 
18x/m.  His axillary temperature was 36°C, with 
body weight of 70 kg, body height of 170 cm, 
and body mass index of 23.4. Auscultation of 
the lungs and heart revealed normal result. The 
abdomen was tender, but we found hepatomegaly 
with smooth surface, sharp margin, and Traube’s 
space dullness. The carotid and radial pulse were 
normal. CNS examination revealed that the 
higher mental functions including the functions 
of cranial nerves and speech were normal. 
Motor system ́and sensory examinations were 
also normal. Examinations and review of other 
systems showed normal results. Investigation 
of hemogram revealed leukocytosis (leukocytes 
of 28,700/mm3 with normal hemoglobin level 
(11 g/dl) and blood chemistry test revealed 
normal results. The albumin and random blood 
glucose levels were normal with Salmonella 
typhi H titer of 1/640, Paratyphi A-B titer 
of 1/640, and paratyphi titer of CH 1/160. 
However, the cytology of red blood smear 
revealed normocytic normochromic red cells. 
Acid fast bacili and gram staining of sputum test 
revealed negative results; however, the result of 
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TB PCR was positive. The ESR was 100-119 
mm/hour, but bilirubin, alkaline phosphatase, 
alfa-fetoprotein and others blood and urine 
parameters were normal.
with rough and heterogenic echo parenchyma 
and bull’s eye sign, which suggested a secondary 
hepatoma of unknown primary origin.
Considering the abovementioned clinical 
features and investigation, patient was diagnosed 
with liver cancer of unknown primary origin.
Due to his complaint of passing pencil-like 
stool and weight loss, he had a colonoscopy 
in Surabaya on April, 4th, 2009. The doctor 
suspected colorectal carcinoma as the primary 
site, but colonoscopy results revealed internal 
hemorrhoids and normal colon (Figure 4).
Figure 1. Chest X-Ray revealed increased bronchovascular 
pattern (increasing KV)
Plain radiographs were taken in March, 31th 
2009. The chest radiographs showed increased 
bronchovascular pattern (Figure 1). We suspected 
a possibility of hillar lymphadenophaty in this 
chest X-ray.
An electrocardiogram revealed a normal 
sinus rhythm at rate of 90/min. Abdominal 
USG and CT scan (Figure 2 and 3) revealed 
hepatomegaly, multiple nodules, hyperechoic 
Figure 2. Abdominal USG revealed multiple nodules in 
right and left lobe of the liver. No calcification/ cystic lesion/ 
papils  was found.
Figure 3. Abdominal CT scan revealed metastatic process 
in the liver with unknown primary origin
Figure 4. The 1st colonoscopy revealed internal hemorrhoid 
and normal colon
Biopsy results revealed lymphocytic 
ileitis and subsequently we found lymph node 
enlargement in supraclavicular region. No 
enlargement was found in the inguinal region. 
Malignant lymphoma was considered as the 
primary origin of liver metastasis since there 
was supraclavicular lymph node enlargement 
and lymphoid cell findings in the 1st ileum 
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biopsy. However, colorectal carcinoma was also 
considered as the primary origin because there 
were changes in bowel habits, hematochezia and 
weight loss.
We continued our investigation by performing 
re-colonoscopy, tumor marker examination, and 
biopsy of liver and supraclavicular lymph nodes 
to find the primary cancer. Investigations of 
tumor marker revealed normal results. The CEA 
level was 50 ng /ml (normal range <5 ng/mL), 
which supported our diagnosis, i.e. colorectal 
carcinoma as the primary cancer. Other tumor 
markers revealed normal results including CA 
19-9 of 20.15 (<37 U/mL), AFP of 1.63 ng/ml 
(<7.2 ng/mL), CA 125 of 15.78 U/mL<35 U/
mL).
 We continued our investigation further by 
performing another colonoscopy and biopsy 
of liver and supraclavicular lymph nodes. The 
last colonoscopy revealed small polyp of 20 
centimeters in size extending from external anal 
orifice.
The final diagnosis of our case was liver 
and lymph node metastasis originated from a 
small polyp in transversal colon. It was actually 
an infiltratrive spread of an adenocarcinoma. 
Based on signs and symptoms of passing mucous 
pencil-like stool, hematoschezia, weight loss, 
hepatosplenomegaly, supraclavicular lymph 
node enlargement, multiple nodules of the liver, 
bull’s eye sign of ultrasonography findings and 
the results of colon biopsy, the diagnosis of 
colorectal carcinoma with metastasis to liver and 
supraclavicular lymph nodes was established.
Fluid  and electrolytes  were  given 
intravenously. We treated the patient using 
125 mg/24 hours intravenous Medixon®, 40 
mg/day Omeprazole, 100 cc of 20% albumin 
transfusion, 20 mg of Atorsan® in the morning 
and Aminofusin® /0.9% normal saline with 
the rate of 21 drops/minute. On the 7th day of 
admission, we performed chemotherapy, using 
Ca leucovorin and 5-Fluorouracyl (De-gramont 
regimen). The patient showed a good response 
to chemotherapy.
The nonproductive cough showed a good 
response to steroid. It is possible that there 
were granulomas such as Koch pulmonum, 
Sarcoidosis or Aspergillosis in this patient 
as a result of impaired immune mechanisms. 
Corticosteroid may acutely suppress the 
manifestations, improves the cough and reveals 
Figure 5. The result of supraclavicular lymph node biopsy 
showed undifferentiated carcinoma metastasis
Figure 6. Liver biopsy revealed metastasis of poorly 
differentiated adenocarcinoma
Figure 7. Rectum biopsy revealed normal result; however, 
the biopsy of transversal colon showed a well-differentiated 
adenocarcinoma
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better result of chest radiograph. However, 
further investigations are necessary to confirm 
the diagnosis of lung process.
DISCUSSION
Colorectal carcinoma is the second leading 
cause of death from gastrointestinal tract (GIT) 
cancer in US. It is the 3rd common malignancy 
in both men and women, after lung, breast or 
prostate carcinoma.1
Most of colorectal carcinoma developed 
metastatic disease (60%). The metastasic process 
to liver alone is account for 50%, which more 
frequently found in sessile polyps. According 
to Petrek, the common location of colorectal 
carcinoma are rectum (22%), recto sigmoid (8%), 
sigmoid (20%), descendingt colon (12%), flexure 
lienalis (8%), transversum (6%), flexure hepatica 
(4%), ascending colon (6%), caecum (12%), and 
appendix (2%) of all colorectal carcinoma.
Signs and symptoms of colorectal carcinoma 
depend on the location and the size of the tumor 
itself. Abdominal pain and polypoid fungating 
are signs and symptoms, which are commonly 
found in carcinoma of caecum and ascending 
colon; while recto sigmoid carcinoma usually 
presents the sign of obstruction/napkin rings 
or bleeding. In addition, colorectal carcinoma 
also may present with abdominal pain (60.5%), 
anemia (21.3%), weight loss (28.8%), changes 
in bowel habits (48%), diarrhea (12.7%), 
hematoschezia (48.5%), hemorrhoid (10.4%), 
abdominal mass (24.2%), rectal mass (7.9%), 
obstruction (17.0%), and asymptomatic (2.5%). 
Sometimes, the tumor invades into the intestine 
wall and perforates. When this occurs, it will 
cause peritonitis and septicemia. If the tumor 
gets ulcerated and involves blood vessel, it may 
cause bleeding.
According to Odone, the first appearance of 
the tumor may need 3-12 months to be noticed; 
while according to Petrek, colorectal carcinoma 
is uncommon in young age patients.1 The 
screening tests include stool examination, barium 
enema and detection of circulating antigen for 
all people over 40 years of age. CEA, a tumor 
marker found by Gold and Freedman, is detected 
in 72-92% of patients with colorectal carcinoma. 
CEA will be increased within 6-10 months before 
signs of metastasis develop or when the signs 
relapse.  It is also will be markedly increased 
in poorly differentiated colorectal carcinoma 
as well as in colorectal carcinoma that has been 
spread to blood vessel and lymphatic nodes.
Supraclavicular lymph node is an unusual 
metastatic site for colorectal carcinoma. It is 
usually a metastatic site for gastric carcinoma. 
Liver metastasis is a common complication 
of cancer occurring in up to 70% of patients 
with advanced breast or prostate cancer and 
approximately 15% to 30% of patients with 
carcinoma of the lung, colon, stomach, bladder, 
uterus, rectum, thyroid, or kidney.2
The patient was first diagnosed with 
carcinoma of unknown origin. Later, he was 
diagnosed with carcinoma of unknown primary. 
Carcinoma of unknown primary (CUP) is 
a biopsy-proven diagnosis of  malignancy 
(mainly epithelial) for which the anatomic site 
of origin remains unidentified after an intensive 
search. CUP is one of the 10 most frequently 
diagnosed cancers worldwide. It contributes 
to approximately 3–5% of all cancer cases.4 
Most investigators rarely consider lymphomas, 
metastatic melanomas, and metastatic sarcomas 
that present without a known primary tumor to 
be CUP since those cancers have specific stage- 
and histological-based treatments.
A standard workup for CUP includes history 
taking, physical examination, and laboratory 
studies such as liver and renal function tests, 
hemogram, chest X-ray, CT scan of the abdomen 
and pelvis, mammography in women, and 
prostate-specific antigen (PSA) test in men.
With increasing availability of additional 
sophisticated imaging techniques and the 
emergence of targeted therapies that have 
been shown to be effective in several cancers, 
oncologists must decide on the extent of workup 
that is warranted. Specifically, they must consider 
how additional diagnostic procedures may affect 
the choice of therapy and the patient’s survival 
and quality of life.
The reason why tumors present as CUP 
remains unclear. One hypothesis is that the 
primary tumor either regresses after seeding 
the metastasis or remains so small that it is 
not detected. It is possible that CUP falls on 
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the continuum of cancer presentation where 
the primary has been contained or eliminated 
by the natural body defenses.3 Alternatively, 
CUP may represent a specific malignant event 
that results in an increase in metastatic spread 
or survival relative to the primary. Whether 
the CUP metastases truly define a clone that is 
genetically and phenotypically unique to this 
diagnosis remains to be determined.3,4 Because 
all these reasons, liver metastasis is a serious 
and costly complication of cancer. The extent of 
angiogenesis in CUP relative to that in metastases 
from known primaries has also been evaluated, 
but no consistent findings have emerged.
Physical examination, including a digital 
rectal examination in men and breast and pelvic 
examinations in women, should be performed. 
Determining the status of patient’s performance, 
nutritional status, co-morbidities and cancer-
induced complications are essential as it may 
affect the treatment strategies.
Most tumor markers, including CEA, CA-
125, CA 19-9, and CA 15-3, when the levels 
are increased, are nonspecific and they are not 
helpful in determining the primary tumor site. 
Men who present with the signs and symptoms 
of adenocarcinoma and osteoblastic metastasis 
should undergo PSA test. Patients with an 
elevated PSA level should be treated as having 
prostate cancer.6
 In patients with undifferentiated or poorly 
differentiated carcinoma (especially those with 
a midline tumor), elevated β-human chorionic 
gonadotropin (βhCG) and α fetoprotein (AFP) 
levels suggest the possibility of an extragonadal 
germ cell (testicular) tumor. Cytogenetic studies 
had a larger role in the past and the interpretation 
of these older studies can be challenging. They 
are indicated only occasionally. We reserve them 
for undifferentiated neoplasm with inconclusive 
immunohistochemical stains and for those for 
with a high suspicion of lymphoma.
Chest X-rays are always planned, but the 
results are often negative, especially with low-
volume disease. CT scans of the chest, abdomen, 
and pelvis can be used to help finding the primary 
tumor, evaluating the extent of disease, and 
selecting the most favorable biopsy site. Older 
studies suggested that the primary tumor site is 
detected in 20–35% of patients who undergo a 
CT scan of the abdomen and pelvis; although 
by current definition these patients would not be 
considered as having CUP. 
Older studies also suggest a latent primary 
tumor prevalence of 20%; however, with 
more sophisticated imaging, this prevalence 
is <10% today. A conventional workup for a 
cervical CUP (a neck lymphadenopathy with 
unknown primary tumor) includes a CT scan or 
MRI and invasive studies such as indirect and 
direct laryngoscopy, bronchoscopy, and upper 
endoscopy. 18 F-fluorodeoxyglucose (FDG) 
positron emission tomography (PET) scans are 
useful in this patient population and  it may 
help in guided biopsy, determining the extent 
of disease, facilitating the appropriate treatment 
including planning radiation fields and providing 
help with disease surveillance.6
Invasive study including upper endoscopy, 
colonoscopy, and bronchoscopy, should be 
limited to symptomatic patients or those with 
laboratory or pathologic abnormalities. It 
suggests that these techniques will result in a 
high tumor yield.
On light microscopy, 60% of CUPs are 
found to be adenocarcinoma and 5% are 
squamous cell carcinoma. The remaining 30% 
of lesions are diagnosed as poorly differentiated 
adenocarcinoma, poorly differentiated 
carcinoma, or poorly differentiated neoplasm. 
A small percentages of lesions are diagnosed 
as neuroendocrine cancers (2%), mixed tumors 
(adenosquamous, or sarcomatoid carcinomas), 
or undifferentiated neoplasm.
In the absence of a known primary cancer, 
developing therapeutic strategies for CUP is 
challenging.5,7 The current diagnostic yield with 
imaging and immunochemistry is ~20–30% for 
CUP patients. The use of gene expression studies 
holds the promise of substantially increasing 
this yield. Gene expression profiles are most 
commonly generated using quantitative RT-PCR 
or DNA micro array.
It is often confused in early identification 
of primary site and management to prevent 
complication of the liver. By a thorough 
understanding of the etiologic factors and 
deforming forces, treatment can be planned for 
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each specific patient.8-10
Virchow’s node (or signal node) is a lymph 
node in the left supraclavicular fossa (the area 
above the left clavicle). It takes its supply from 
lymph vessels in the abdomen cavity. The finding 
of an enlarged and hard node (also referred to 
as Troisier’s sign) has long been regarded as 
strongly indicative for the presence of cancer in 
the abdomen, particularly the gastric cancer  that 
has spread through the lymph vessels.
CONCLUSION
The liver metastasis commonly remains 
unrecognized, particularly in the acute phase, 
until severe complications occur.
We should perform biopsy although we 
could only find minimal lesion in colonoscopy /
endoscopy examination 
Early recognition and diagnosis as well as 
treatment strategies can be better formulated for 
the possible outcomes.
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